See also this year's filing and all EDGAR filings for this company.
PDF Report 0001442999_2023_Alterola_Biotech_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 7.881091330258678e-06, 'aggregate_val': 6471134, 'exp_sum': 6471185, 'exp_to_value': {'GeneralAndAdministrativeExpense': 93206, 'ResearchAndDevelopmentExpense': 341286, 'remainder_Expenses': 6036693}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001442999')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001442999, Alterola Biotech INC
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesNoncurrent | 0 |
| 1 | LiabilitiesCurrent | 1,037,465 |
| 2 | remainder_Liabilities | 164,220 |
| 3 | AssetsCurrent | 127,961 |
| 4 | AssetsNoncurrent | 0 |
| 5 | PropertyPlantAndEquipmentNet | 0 |
| 6 | Goodwill | 0 |
| 7 | remainder_Assets | 12,000,000 |
| 8 | GeneralAndAdministrativeExpense | 93,206 |
| 9 | ResearchAndDevelopmentExpense | 341,286 |
| 10 | remainder_Expenses | 6,036,642 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 1,201,685 |
| 1 | Assets | 12,127,961 |
| 2 | Expenses | 6,471,134 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 10,926,276 |
| 5 | NetIncome | -6,471,134 |
| 6 | ComprehensiveNetIncome | -6,471,134 |
| 7 | BaseVar | 9,900,390 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.28 |
| 9 | EconomicCapitalRatio | 1.86 |
Edgar->Model Mapping
Feature Distribution
